BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 2:51:00 PM | Browse: 1298 | Download: 1134
 |
Received |
|
2013-09-25 10:20 |
 |
Peer-Review Started |
|
2013-09-25 16:15 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-12-27 12:17 |
 |
Revised |
|
2014-01-06 14:52 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-01-20 17:18 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-01-20 18:20 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-03-03 17:20 |
 |
Publish the Manuscript Online |
|
2014-03-18 14:14 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Vo Duy Thong, Srunthron Akkarathamrongsin, Kittiyod Poovorawan, Pisit Tangkijvanich and Yong Poovorawan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Unit of Hepatitis and Liver Cancer, Chulalongkorn University |
|
| Scholarship Program for Neighboring Countries, Chulalongkorn University |
|
| Higher Education Research Promotion and National Research University Project of Thailand |
HR1155A-55 |
| Thailand Research Fund |
DPG5480002 |
| Thailand Research Fund |
BRG5580005 |
| Office of the Commission on Higher Education |
|
| Center of Excellence in Clinical Virology, Chulalongkorn University |
|
| Integrated Innovation Academic Center IIAC Chulalongkorn University Centenary Academic Development Project |
CU56-HR01 |
| Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University |
RES560530093 |
| King Chulalongkorn Memorial Hospital |
|
|
| Corresponding Author |
Yong Poovorawan, MD, Professor, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. yong.p@chula.ac.th |
| Key Words |
Hepatitis C virus; Genotype 6; Epidemiology; Clinical; Treatment |
| Core Tip |
Hepatitis C virus (HCV) genotype 6 is restricted to South China, South-East Asia, and it is occasionally found in migrant patients from endemic countries. Treatment response rates are lower than those of genotype 3 but higher than those of genotype 1. Based on current evidence, the optimal treatment duration of HCV-6 should be 48 wk. Shortened treatment duration of 24 wk could be sufficient in patients with low pretreatment viral load who achieve rapid virological response. The development of direct-acting antiviral agents is ongoing, and they give high response rate when combined with standard therapy. We review the epidemiology, classification, diagnosis and treatment. |
| Publish Date |
2014-03-18 14:14 |
| Citation |
Thong VD, Akkarathamrongsin S, Poovorawan K, Tangkijvanich P, Poovorawan Y. Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 2014; 20(11): 2927-2940 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i11/2927.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i11.2927 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.